Legal Opinion
Janssen Pharmaceuticals, Inc. v. Tolmar, Inc.
District Court, D. Delaware
Decided June 13, 2024No. 1:21-cv-01784Unknown
1Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE JANSSEN PHARMACEUTICALS, § INC. and JANSSEN PHARMCEUTICA § NV, § § Plaintiffs, § § v. § Civil Action No. 21-1784-WCB § TOLMAR, INC., § § Defendant. § § OPINION AND ORDER ON RECONSIDERATION Plaintiffs Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV (collectively “Janssen”) sued Tolmar, Inc., for patent infringement under the Hatch-Waxman act. After a four- day bench trial, the court issued findings of facts and conclusions of law, in which it found all the asserted claims of
U.S. Patent No. 9,439,906
(“the ’906 patent”)…
2Cases cited4 opinions
- In Re Pravin L. Soni, Ceinwen Rowlands, Larry Edwards and Mark WartenbergCourt of Appeals for the Federal Circuit · 1995
- Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2014
- Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2024
- Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2024